Elizabeth McKenna @ElizSMcKenna Twitter profile

Pinned Tweet

Elizabeth McKenna

29 days

✨It's here!! The April special issue of @CD_AACR is now online!! The issue includes commentaries selected from the call issued last Fall and MUCH more! Check back here for highlights today and throughout #AACR24 !

0

10

46

Last Seen Profiles

@haru812s

@Au75883661Marco

@caresforaz

@k9mi__

@Siiimpppppp

@glamdoodle

@JoshEngleman

@Yumi_Trap

@yumedojosapporo

@MirletteGonzlez

@MichaelChongMP

@IamRodrigo

@LadiesAwakening

@Ditrestless

@yukku_ri

@Danielo88010595

@EternalSunProd

@momopoukss2008

@kontiokaveri

@redet_tacheles

@DevOliRBX

@CarlosS84550989

@yasan_mofumofu

@7StrongSoftball

@dlew919

@InodoroPer25877

@GetLocoNow

@CHCHNews

@total_death

@polygon_io

@eststormcloak

@9ae03df3d56544f

@bigrig_tv

@KrissJinn

@Beyond2039

@DianaMarateixe4

Elizabeth McKenna

@ElizSMcKenna

2 years

Excited to share some good news: I've been named to this year's list of "40 Under 40 in Cancer"! Congratulations to all of the 2021 #40under40incancer awardees!

60

22

620

Elizabeth McKenna

@ElizSMcKenna

2 years

Calling all new PIs/soon-to-be #newPI studying cancer! If I'm not following you already please say hi and what you work on so I can follow you! 😃

144

74

534

Elizabeth McKenna

@ElizSMcKenna

2 years

⭐️SO excited to finally be able to share the January issue of @CD_AACR , which includes "Hallmarks of Cancer: New Dimensions" by #DougHanahan !!

6

87

413

Elizabeth McKenna

@ElizSMcKenna

3 years

🎉🎉🎉🎉🎉🎉🎉🎉🎉🎉🎉

Cancer Discovery

@CD_AACR

3 years

Cancer Discovery's new Impact Factor is 39.397! Thank you to our authors, reviewers and editors for their contributions!

11

39

262

28

17

322

Elizabeth McKenna

@ElizSMcKenna

2 years

🚨🚨🚨NEW "HALLMARKS OF CANCER" PUBLISHED TODAY IN @CD_AACR !!!🚨🚨🚨

Cancer Discovery

@CD_AACR

2 years

Just published! We proudly present "Hallmarks of Cancer: New Dimensions" by Douglas Hanahan, the third update to the seminal series. @Ludwig_Cancer

23

875

2K

2

65

261

Elizabeth McKenna

@ElizSMcKenna

2 years

I have 10,000 followers today! Using Twitter over the past few years has been incredibly rewarding both professionally and personally, especially during the last few years when meeting in person wasn't possible. I feel very fortunate to be able to connect with you all!!

11

4

237

Elizabeth McKenna

@ElizSMcKenna

2 years

I really enjoyed putting this collection featuring impactful papers from the last decade together for @CD_AACR ’s 10th Anniversary! Come pick up a copy at booth 2101 #AACR22 !

7

233

Elizabeth McKenna

@ElizSMcKenna

2 years

Excited for a busy day at #AACR22 !

2

3

230

Elizabeth McKenna

@ElizSMcKenna

3 years

I joined @AACR @CD_AACR 10 years ago today! It's been so incredibly rewarding to work with a great team and the cancer research community to contribute to the journal's success! I wanted to share some of my favorite moments from the past decade - first up, Day 1 in 2011:

14

4

187

Elizabeth McKenna

@ElizSMcKenna

3 years

Shocked and saddened to hear of the passing of Jose Baselga, a giant in precision oncology. He was founding co-editor-in-chief of @CD_AACR and his vision continues to guide the journal. I’ll always remember his kindness and support as I began my editorial career.

2

12

176

Elizabeth McKenna

@ElizSMcKenna

1 year

⭐️Now online in @CD_AACR : Efficacy of a Small-Molecule Inhibitor of #KRAS G12D (!!) in Immunocompetent Models of #PancreaticCancer - by @sam_kemp20 , Robert Vonderheide, @BenStanger01 and colleagues @PennMedicine @PennCancer

3

61

169

Elizabeth McKenna

@ElizSMcKenna

2 years

Doug Hanahan talking about his addition of nonmutational epigenetic reprogramming in this year’s #HallmarksofCancer update in @CD_AACR as an enabling characteristic #EMBOCancerEvolution

4

24

163

Elizabeth McKenna

@ElizSMcKenna

26 days

Finally here in San Diego after preparing for #AACR24 for so long!! See everyone soon!!

4

3

169

Elizabeth McKenna

@ElizSMcKenna

11 months

It's that time of year - calling all new #cancer PIs starting/about to start their labs! Please say hi and what you work on so I can follow you if I don't already! 😃 #NewPI

28

33

167

Elizabeth McKenna

@ElizSMcKenna

4 years

Great news!!

Cancer Discovery

@CD_AACR

4 years

In support of researchers working remotely, all @AACR journal content, including the most recent scientific research, is now free to access to ensure that you have the information you need during this challenging time. #openaccess #coronavirus

0

29

90

3

28

162

Elizabeth McKenna

@ElizSMcKenna

2 years

An unexpected surprise at the #AACR22 celebration honoring @AACR 2020-2021 President Toni Ribas - a performance by ⁦ @JimAllisonPhD ⁩ and #TheCheckpoints !!

1

12

155

Elizabeth McKenna

@ElizSMcKenna

3 years

MRTX1133 is an selective non-covalent inhibitor of KRAS G12D #Targets21

4

43

148

Elizabeth McKenna

@ElizSMcKenna

3 years

Such sad news about Alex Trebek. Right before we took this souvenir picture when I was on Jeopardy! he said, “Together again, for the first time!” A delightfully weird thing to say that I will always remember.

4

1

149

Elizabeth McKenna

@ElizSMcKenna

3 years

Realized today is the anniversary of my defense which turns out to be #WomenInScienceDay ! Grateful for all of the inspiring women I’ve encountered throughout my time in the lab and at @CD_AACR ! @TheRobertsLab1 @BBS_Harvard #WomenInScience

0

7

147

Elizabeth McKenna

@ElizSMcKenna

3 years

It’s here!! We are so excited to present our first-ever special issue to commemorate the 10th Anniversary of @CD_AACR !! In this issue, leaders in the field discuss some of the biggest unanswered questions in cancer research and look ahead to the future #CDturns10 /1

1

54

138

Elizabeth McKenna

@ElizSMcKenna

1 year

Moved to a new office - getting ready to reinstall my “wallpaper” of 11 years’ worth of @CD_AACR covers 😁

8

1

137

Elizabeth McKenna

@ElizSMcKenna

3 years

🚨Now in @CD_AACR ! A first example of clinical resistance to #KRAS #G12C inhibition – polyclonal alterations converge on RAS-MAPK activation, including a never-before-seen KRAS Y96D mutation affecting the switch-II pocket where G12C inhibitors bind! 🤯 /1

4

58

133

Elizabeth McKenna

@ElizSMcKenna

1 year

Now in @CD_AACR : Human #BoneMarrow #Organoids for Disease Modelling, Discovery & Validation of Therapeutic Targets in Hematological Malignancies by Abdullah Khan @theclotthickens @beth_psaila et al. @unibirmingham @BostonChildrens @MRC_WIMM @UniofOxford

5

34

133

Elizabeth McKenna

@ElizSMcKenna

3 years

So excited we are kicking off the @CD_AACR 10th Anniversary celebration! Join us this year as we highlight significant discoveries published over the last decade and recognize authors for their contributions to the success of the Journal! @AACR #CDturns10

6

24

133

Elizabeth McKenna

@ElizSMcKenna

2 months

Good morning London! Just arrived for the @CancerGrand Challenges Summit and stopped for breakfast with a view at @DuckandWaffle 🇬🇧

7

1

123

Elizabeth McKenna

@ElizSMcKenna

7 months

What an honor to be included in this group!

OncoDaily

@oncodaily

7 months

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 8 🇺🇸🇸🇪🇦🇺🇨🇦🇩🇪🇵🇹🇲🇾 Again its Saturday, and we continue OncoDaily's series on '100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in…

6

20

79

7

4

119

Elizabeth McKenna

@ElizSMcKenna

1 year

NPM1 is one of the most frequently mutated genes in leukemia but the role of mutant NPM1 in leukemogenesis has been unclear. Now online in @CD_AACR , two back-to-back studies from the labs of @zxtzhangqian @LilingWanLab @schong_ustc and of @Armstrong_dfci address this question 1/3

2

22

115

Elizabeth McKenna

@ElizSMcKenna

7 months

Is p53 the next "undruggable" target to become druggable in cancer? For more, read this recent @CD_AACR paper by Keelan Guiley & @kevansf : A Small Molecule Reacts with the #p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability #Targets23 @UCSF

0

40

112

Elizabeth McKenna

@ElizSMcKenna

5 years

Just published in @CD_AACR to coincide with the highly anticipated presentation at #Targets19 : The #KRASG12C Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of #KRAS Mutant Cancers in Mouse Models and Patients

3

39

111

Elizabeth McKenna

@ElizSMcKenna

26 days

CONGRATULATIONS to the inaugural @CD_AACR Early Career Award winner: @DirenaAC !!! 🎉🎉 #AACR24

7

4

110

Elizabeth McKenna

@ElizSMcKenna

2 years

On my way!! ✈️🇮🇹 #EMBOCancerEvolution

4

2

107

Elizabeth McKenna

@ElizSMcKenna

2 years

At the final #AACR22 Plenary Session on Tumor Evolution and Therapeutic Resistance? Don't miss the @CD_AACR review by speaker @CharlesSwanton & colleagues @TheCrick : Tracking #CancerEvolution through the Disease Course

0

30

107

Elizabeth McKenna

@ElizSMcKenna

28 days

Out today in @CD_AACR ! #CancerHallmarks : Piecing the Puzzle Together 🧩 @AmbrogioLab @MariaPAlcolea @gemmakelly_1 @waileongtam @theLundLab @alpcorreia @CJHPhD @IngunnStromnes @DanielaQuail @ErnstAurelie @DirenaAC @ShemaEfrat @BullmanLab @Marcus_Ruscetti

7

30

107

Elizabeth McKenna

@ElizSMcKenna

2 years

First meal! Best train station food! At Bologna Centrale 🚄🇮🇹

8

0

107

Elizabeth McKenna

@ElizSMcKenna

1 year

At the #AACR23 session on #ClonalHematopoiesis ? Don't miss this review by @ThomasKoehnke & @RaviMajetiMD @majetilab @StanfordMed - Clonal Hematopoiesis: from Mechanisms to Clinical Intervention

0

38

105

Elizabeth McKenna

@ElizSMcKenna

2 years

Now online in @CD_AACR : Back-to-back papers from the groups of @DirenaAC / @LoweLabMSKCC & @FedericoPietr12 /Manuel Serrano showing cellular #senescence promotes anti-tumor #immunity : 👇🧵

1

28

107

Elizabeth McKenna

@ElizSMcKenna

2 years

Outfits selected, bag packed, tweets scheduled, COVID test negative, ready to go to #AACR22 !! See everyone soon 🤞🏻🎉

2

1

105

Elizabeth McKenna

@ElizSMcKenna

4 years

Congratulations to Drs. Charpentier and Doudna on winning the #NobelPrize in Chemistry!! It’s hard to overstate the impact of CRISPR-based genome editing on cancer research over the past decade.

The Nobel Prize

@NobelPrize

4 years

BREAKING NEWS: The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”

729

25K

49K

0

7

105

Elizabeth McKenna

@ElizSMcKenna

2 years

Now online in @CD_AACR : The Impact of #Inflammation -induced Tumor #Plasticity During #Myeloid Transformation - by @AnnaYeaton Geraldine Cayanan @Maguillamot @iannisaifantis1 and colleagues @Perlmutter_CC @nyugrossman @nyulangone #ClonalHematopoiesis

0

20

105

Elizabeth McKenna

@ElizSMcKenna

2 years

Attending the final #AACR22 Plenary Session on Tumor Evolution and Therapeutic Resistance? Don't miss this @CD_AACR review: Overcoming Resistance to Tumor-Targeted & Immune-Targeted Therapies @mihaela_aldea @FAndreMD @barlesi @jsoriamd @GustaveRoussy

1

38

102

Elizabeth McKenna

@ElizSMcKenna

2 years

Now online in @CD_AACR : Stromal Reprogramming by FAK Inhibition Overcomes #RadiationTherapy Resistance to Allow for Immune Priming and Response to Checkpoint Blockade @DeNardoLabWUSM @WUSTLmed @SitemanCenter #PancreaticCancer #Immunotherapy

0

20

105

Elizabeth McKenna

@ElizSMcKenna

28 days

Out today in @CD_AACR ! ⭐️The Hallmarks of Precancer⭐️ - by @MMStangis , Zhengyi Chen, Jimin Min, Sarah Glass, Jordan Jackson, @radykm , @DeySciences , @KenLauLab , and colleagues

2

32

103

Elizabeth McKenna

@ElizSMcKenna

2 years

On my way to London for #BicConf22 and visits to @imperialcollege and @TheCrick ! Wearing my @AFCRichmond shirt in case I run into @TedLasso or @TheRealRoyKent 😁

3

0

104

Elizabeth McKenna

@ElizSMcKenna

3 years

Very excited I now have a virtual background of my office full of @CD_AACR covers 😂

1

102

Elizabeth McKenna

@ElizSMcKenna

3 years

So many #AACRMemories to share! My very first one was from 2011 in Orlando, when I presented a poster on my work in @TheRobertsLab1 and found out about a job opening at the brand new journal @CD_AACR !

4

1

97

Elizabeth McKenna

@ElizSMcKenna

2 years

And that's a wrap on #AACR22 - thank you for following along, and it was SO GOOD to be with everyone in person! Can't wait for #AACR23 !!

2

5

95

Elizabeth McKenna

@ElizSMcKenna

2 years

Backstage at the #AACR22 Plenary with @CD_AACR co-Editor-in-Chief Luis Diaz (who is speaking soon)!

1

7

93

Elizabeth McKenna

@ElizSMcKenna

2 years

If you're watching the #AACR22 session on Drug Resistance Challenges/Prospects - don't miss the review in @CD_AACR by speaker @sorger_peter : Independent Drug Action in Combination Therapy: Implications for Precision Oncology @PlanaDeborah @ac_palmer

1

25

94

Elizabeth McKenna

@ElizSMcKenna

1 year

🧬Now online in @CD_AACR for #AACRprev22 : Nucleosome Patterns in #ctDNA Reveal Transcriptional Regulation of Advanced #ProstateCancer Phenotypes by @Navonilde , Robert Patton, Peter Nelson, @GavinHa & colleagues @fredhutch #LiquidBiopsy #cfDNA

2

35

90

Elizabeth McKenna

@ElizSMcKenna

2 years

Fish and chips at the airport before heading back to the US! ✈️ Until next time, England!

5

0

90

Elizabeth McKenna

@ElizSMcKenna

2 years

Made it to the airport in time to have one last snack. Ciao, Italia!

2

0

89

Elizabeth McKenna

@ElizSMcKenna

2 months

Heading home to the US ✈️🇺🇸 inspired by the amazing science and collaborative spirit on display at the #CancerGrandChallenges Summit - congratulations again to the outgoing, current, and new teams, and thank you to the @CancerGrand team for an awesome event!

0

90

Elizabeth McKenna

@ElizSMcKenna

2 years

Starting my last day in #London with a visit to @CharlesSwanton and colleagues at @TheCrick - what an amazing building! 🧬

4

1

90

Elizabeth McKenna

@ElizSMcKenna

23 days

Toasting a successful #AACR24 so far with @HarmonyTurk !

0

2

89

Elizabeth McKenna

@ElizSMcKenna

1 year

Finally done! And just in time to add the December @CD_AACR cover 🤩

Elizabeth McKenna

@ElizSMcKenna

1 year

Moved to a new office - getting ready to reinstall my “wallpaper” of 11 years’ worth of @CD_AACR covers 😁

8

1

137

8

2

87

Elizabeth McKenna

@ElizSMcKenna

2 years

Next up: #ASCO22 ! Please reach out if you’ll be in Chicago and would like to meet!

4

1

87

Elizabeth McKenna

@ElizSMcKenna

1 year

A bit bleary-eyed on the last morning of #AACR23 but I’ve had a fantastic time hearing about amazing science and catching up with everyone!

0

3

86

Elizabeth McKenna

@ElizSMcKenna

2 years

It’s #AACR22 badge pickup day at @AACR HQ!! T-1 week!!! 👏🏻🎉✈️

2

1

85

Elizabeth McKenna

@ElizSMcKenna

2 years

Amazing to see how tweets about the update to #HallmarksofCancer published in @CD_AACR yesterday have come from all over the world!! 🌎 Read it here:

3

85

Elizabeth McKenna

@ElizSMcKenna

6 months

Now in @CD_AACR : Loss-of-Function but Not Gain-of-Function Properties of Mutant #p53 Are Critical for the Proliferation, Survival, & Metastasis of a Broad Range of Cancer Cells - by Zilu Wang, @gemmakelly_1 , Andreas Strasser, et al. @WEHI_research @UniMelb

2

25

85

Elizabeth McKenna

@ElizSMcKenna

10 months

Now online in @CD_AACR : Sex-biased T cell Exhaustion Drives Differential Immune Responses in #Glioblastoma @JuyeunLee31 @JustinLathia @ClevelandClinic @caseccc

1

26

81

Elizabeth McKenna

@ElizSMcKenna

9 months

Now online at @CD_AACR , a provocative study by @austinkmattox , Bert Vogelstein, et al: The Origin of Highly Elevated #cfDNA in Healthy Individuals & Patients w/Pancreatic, Colorectal, Lung, or Ovarian Cancer @hopkinskimmel @Ludwig_Cancer #liquidbiopsy

1

25

81

Elizabeth McKenna

@ElizSMcKenna

4 years

Bittersweet day - really sad we're not all in San Diego, but excited for the Virtual Annual Meeting #AACR20 to start and proud of my @AACR colleagues for making it happen!

1

6

80

Elizabeth McKenna

@ElizSMcKenna

3 years

On the cover of the July issue of @CD_AACR , we honor the late José Baselga, founding co-Editor-in-Chief of the Journal. Portrait by Nicolle Fuller of @SayoStudio

0

16

79

Elizabeth McKenna

@ElizSMcKenna

3 years

While preparing for the #AACR21 @CD_AACR Meet the Editors session earlier today, I found this picture of José Baselga, ⁦ @AACR_CEO ⁩, and ⁦ @CantleyLab ⁩ at the launch of Cancer Discovery at the 2011 AACR Annual Meeting #AACRMemories #CDturns10

3

5

79

Elizabeth McKenna

@ElizSMcKenna

4 months

Now online in @CD_AACR : JAK2 V617F Reversible Activation Shows Its Essential Requirement in #MyeloproliferativeNeoplasms - by Andrew Dunbar, @bowman_rl , @rosslevinemd , @RossLevineLab and colleagues @MSKCancerCenter #mpnsm

1

13

78

Elizabeth McKenna

@ElizSMcKenna

3 months

Now online in @CD_AACR : Overcoming Clinical Resistance to #EZH2 Inhibition Using Rational Epigenetic Combination Therapy @YKazansky @oleg8r @KentsisResearch @MSKCancerCenter

2

18

75

Elizabeth McKenna

@ElizSMcKenna

4 months

Happy Holidays from the @CD_AACR team!

2

1

77

Elizabeth McKenna

@ElizSMcKenna

3 years

Exciting news! Today I'm thrilled to welcome @DrBaileeSliker to the @CD_AACR team as our new Assistant Editor! Bailee joins us from @FoxChaseCancer where she was studying the role of KRAS in pancreatic cancer. Please follow her and keep an eye out for her at meetings!

5

4

77

Elizabeth McKenna

@ElizSMcKenna

1 year

Wrapping up a great visit to ⁦ @bcmhouston ⁩ and ⁦ @MDAndersonNews ⁩ - you could spend 2 weeks in the Texas Medical Center area and still not get a chance to meet everyone! Until next time!

3

2

74

Elizabeth McKenna

@ElizSMcKenna

2 years

Now online in @CD_AACR : Zenocutuzumab, a #HER2 x #HER3 #bispecific antibody, is effective therapy for tumors driven by #NRG1 gene rearrangements - by @AliSchram @odintosov_I Romel Somwar and colleagues @sloan_kettering

Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene...

Zenocutuzumab, a HER2xHER3 bispecific antibody, reduces cell growth in NRG1-rearranged cancer cell lines and xenografts and induces durable clinical responses in patients with NRG1 fusion–positive...

aacrjournals.org

1

24

74

Elizabeth McKenna

@ElizSMcKenna

4 months

Now online in @CD_AACR : #Sotorasib Is a pan-RAS G12C Inhibitor Capable of Driving Clinical Response in NRAS G12C cancers - by @Labrat3 , Noritaka Tanaka, Andy Aguirre, Ryan Corcoran, and colleagues @DanaFarber @MGHCancerCenter #KRAS

0

19

73

Elizabeth McKenna

@ElizSMcKenna

2 years

Interested in the #AACR22 session on #Metabolism , #Inflammation , and #Immunotherapy ? Check out the @CD_AACR minireview by @madden_mz and @JeffRathmell @VUMC_VCI on The Complex Integration of T-cell Metabolism and Immunotherapy

1

15

71

Elizabeth McKenna

@ElizSMcKenna

2 years

Getting so excited for #AACR22 ! Please reach out via email or DM if you'd like to set up a time to talk about your work or have any questions about @CD_AACR !

2

10

72

Elizabeth McKenna

@ElizSMcKenna

2 months

The fourth winning @CancerGrand team is a second (!) team for the Solid Tumors in Children challenge: Team PROTECT, led by Stefan Pfister ( @KiTZ_HD ) - congratulations!

1

16

71

Elizabeth McKenna

@ElizSMcKenna

4 years

So proud to have been a part of this work🤩 @TheRobertsLab1

St. Jude Research

@StJudeResearch

4 years

Tazemetostat is approved for treatment of rare epithelioid sarcoma treatment. Dr. Charles Roberts’ 2010 @Cancer_Cell paper helped lay groundwork for this approval, suggesting an EZH2 inhibitor could be used to treat cancers with SMARCB1/INI1 deficiencies.

0

16

48

2

6

71

Elizabeth McKenna

@ElizSMcKenna

5 months

Perfect timing with the announcement of what is sure to be an amazing meeting organized by @obenaufa , @LeilaAkkari1 , @CirielloLab and @MagnaniLab_ICR - a review now online in @CD_AACR by the speakers from the unforgettable inaugural meeting #EMBOCancerEvo

Anna Obenauf

@obenaufa

5 months

🌟We are delighted to invite you to our EMBO Workshop on "The many faces of cancer evolution" in a breathtaking location! Enjoy interdisciplinary discussions, get new perspectives, and make new friends over an aperitivo! #EMBOcancerEvo 📅 Don't miss out:

2

17

101

1

15

70

Elizabeth McKenna

@ElizSMcKenna

3 years

#tbt 10 years ago - ad hoc hooding ceremony in the Mayer 6 conference room 👩🏻‍🎓 @DanaFarber ⁩ @TheRobertsLab1 ⁩

2

0

70

Elizabeth McKenna

@ElizSMcKenna

2 years

Highly recommend this touching tribute and inspiring documentary about José Baselga. It was a honor to work him at @CD_AACR and it is amazing to see his continued impact on translational cancer research.

How One Doctor Changed Cancer Care Forever

Dr. José Baselga experienced triumphs and overcame challenges to become a once-in-a-generation scientist. Meet the visionary oncologist who transformed cancer treatment.

www.theatlantic.com

1

11

68

Elizabeth McKenna

@ElizSMcKenna

11 months

Now online in @CD_AACR : #SpatialTranscriptomics of Intraductal Papillary Mucinous Neoplasms ( #IPMN ) of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential @Marta_Sans_ @Aiims1742 @MDAndersonNews

2

22

68

Elizabeth McKenna

@ElizSMcKenna

3 years

Now online in @CD_AACR : SMARCA4 inactivation promotes lineage-specific transformation and early metastatic features in the lung @cp_concepcion @LabJacks @kochinstitute @MITBiology #lungcancer

0

18

67

Elizabeth McKenna

@ElizSMcKenna

1 year

State unlocked: Texas! Excited to spend the next few days visiting ⁦ @bcmhouston ⁩ and ⁦ @MDAndersonNews ⁩!!

3

0

67

Elizabeth McKenna

@ElizSMcKenna

25 days

The rumors of a selfie wall at the @AACR Pubs Booth (4043) are true! Come to the #AACR24 journals social media meetup Monday at 4pm to meet me and other editors!!

2

4

68

Elizabeth McKenna

@ElizSMcKenna

3 years

I reached 5,000 Twitter followers over the weekend! 🎉Thank you all for following and connecting with me, especially over the past year!

3

0

68

Elizabeth McKenna

@ElizSMcKenna

2 years

On our way to #ASH21 !! ✈️🎉⁦ @_TanyaBondar_ ⁩ @CD_AACR ⁦ @BCD_AACR ⁩

4

2

68

Elizabeth McKenna

@ElizSMcKenna

3 years

So excited to "go back" to Singapore next week to talk about @CD_AACR and to hear about exciting research going on at @dukenus @astar_research @astar_gis ! I wish I had some kopi but will pass on more durian!

8

2

68

Elizabeth McKenna

@ElizSMcKenna

1 year

New favorite British road sign. #London

2

0

68

Elizabeth McKenna

@ElizSMcKenna

6 months

A day in Madrid before #CFM_Metastasis starts!

5

0

66

Elizabeth McKenna

@ElizSMcKenna

1 year

Headed to New Orleans this Friday for #ASH22 ! Looking forward to seeing everyone - please reach out if you’d like to meet to discuss your work!

6

3

67

Elizabeth McKenna

@ElizSMcKenna

4 years

We are sad that #AACR20 was postponed but the @CD_AACR team is looking forward to seeing everyone when it is rescheduled!!

1

2

67

Elizabeth McKenna

@ElizSMcKenna

3 years

And that's a wrap for #AACR21 !! Can't wait to see you all in person in New Orleans next year!!

2

3

66

Elizabeth McKenna

@ElizSMcKenna

2 years

Back from break! Best wishes to everyone for a happy and healthy new year, and thank you to the authors, reviewers, and readers of @CD_AACR for your support in 2021. Keep an eye out for some really exciting content later this month!!

1

66

Elizabeth McKenna

@ElizSMcKenna

11 months

Wrapped up my brief NYC trip at @MSKCancerCenter today! Thanks to @AbdelWahablab for hosting and for everyone who made time to speak with me! Definitely will be back in NY ASAP!

2

0

66

Elizabeth McKenna

@ElizSMcKenna

1 year

How it started #AACR11 How it’s going #AACR23 @TheRobertsLab1 #Orlando

2

1

65

Elizabeth McKenna

@ElizSMcKenna

4 months

Taking a break from posting about science to share my 5 favorite books I read this year:

3

4

64

Elizabeth McKenna

@ElizSMcKenna

2 years

#AACR22 starts today!! Are you following all of the other @AACR journal editors who are on Twitter?? @imsmd @TaliLev123 @DrBaileeSliker @HarmonyTurk @Marlowe_Tessmer @_TanyaBondar_ @DaveGennert @khoney74 @Adri_CIR @JingPeng123

0

10

65

Elizabeth McKenna

@ElizSMcKenna

1 month

Now online in @CD_AACR : BRCA1-mediated Dual Regulation of #Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-inhibition in BRCA1-deficient Cancers - by Guang Lei @BoyiGan and colleagues @MDAndersonNews

0

32

64

Elizabeth McKenna

@ElizSMcKenna

2 years

Exciting news about the launch of the James P. Allison Institute for #immunotherapy at @MDAndersonNews ! ICYMI in the 10th Anniversary Issue of @CD_AACR by @PamSharmaMDPhD @JimAllisonPhD and colleagues: The Next Decade of Immune Checkpoint Therapy

The Next Decade of Immune Checkpoint Therapy

AbstractImmune checkpoint therapy (ICT) can provide durable clinical responses and improve overall survival. However, only subsets of patients with specific tumor types respond to ICT. Thus, signif...

aacrjournals.org

0

12

65

Elizabeth McKenna

@ElizSMcKenna

2 years

Recording something for #ESMO22 ! Stay tuned! @OncoAlert